Navigation Links
Par Pharmaceutical Begins Shipment of KHEDEZLA (desvenlafaxine) Extended-release Tablets, 50 mg and 100 mg
Date:9/23/2013

WOODCLIFF LAKE, N.J., Sept. 23, 2013 /PRNewswire/ -- Par Pharmaceutical Companies, Inc. today announced that it has begun shipping KHEDEZLA (desvenlafaxine) Extended-release (ER) Tablets, 50 mg and 100 mg.  Par's development partner, Osmotica Pharmaceutical Corp., received approval for its New Drug Application (NDA) for KHEDEZLA ER Tablets from the U.S. Food and Drug Administration pursuant to section 505(b)(2) of the Federal Food, Drug, and Cosmetic Act.  KHEDEZLA is indicated for the treatment of major depressive disorder (MDD).  KHEDEZLA provides patients and physicians with additional options in the treatment of major depressive disorder. 

Osmotica's NDA included comparative bioequivalence testing against Pfizer's PRISTIQ® (desvenlafaxine) Extended-Release Tablets. KHEDEZLA is not generically substitutable for PRISTIQ 50 mg and 100 mg tablets. According to IMS Health data, annual U.S. sales of PRISTIQ are approximately $614 million. 

Under terms of its agreement with Osmotica, Par will market, sell and distribute KHEDEZLA in the United States. Par will share profits from the sales of the product with its development partner.  

Important Information about KHEDEZLA ER Tablets 
A black box warning is associated with this product regarding increased risk of suicidal thoughts and behaviors in children, adolescents and young adults taking antidepressants.  All persons taking KHEDEZLA should be monitored for worsening and emergence of suicidal thoughts and behaviors.  KHEDEZLA is not approved for use in pediatric patients. Refer to full prescribing information for complete boxed warning.

KHEDEZLA (desvenlafaxine) Extended-release Tablets are contraindicated in patients who are hypersensitive to desvenlafaxine succinate, venlafaxine hydrochloride or to any component of the product.  Angioedema has been reported in pa
'/>"/>

SOURCE Par Pharmaceutical Companies, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Immune Pharmaceuticals Inc. Trading Symbol is Now IMNP on Both NASDAQ OMX Stockholm Exchange and OTCQX Trading Platform
3. Isis Pharmaceuticals to Conduct Webcast and Conference Call to Discuss ISIS-APOCIII Rx Phase 2 Data
4. Harwood Feffer LLP Announces Investigation of Transcept Pharmaceuticals, Inc.
5. New Pharmaceutical Product Launch Spend: Developing Competitive Launch and Pre-launch Budgets to Ensure a Successful Market Entry
6. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
7. Auxilium Pharmaceuticals, Inc. Raises $50 Million In Additional Financing
8. Thomson Reuters Reveals New Strategies for Navigating Big Data in the Pharmaceutical Industry
9. Rafarma Pharmaceuticals, Inc. (RAFA) announces plans for PCAOB-Registrant Audit and Streamlining of Corporate Structure to Upgrade Market Listing.
10. Legal Actions, Quarterly Dividends, Collaborations, and New Appointments - Research Report on Johnson & Johnson, Zoetis, Abbott, Teva Pharmaceuticals, and Baxter
11. Amgen and Onyx Pharmaceuticals Announce Early Termination of HSR Waiting Period for Amgens Acquisition of Onyx
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... and LONDON , August 26, 2014 ... FDNA Inc. ( http://www.fdna.com ) and London Medical Databases ... partnered to offer, for the first time, online access ... FDNA, developer of the Facial Dysmorphology ... collection into Face2Gene [ TM ] , ...
(Date:8/26/2014)... SAN DIEGO , Aug. 26, 2014   ... M.D., has been named vice president, clinical development, and ... president, clinical operations. "As we advance ... we are expanding our clinical team with individuals who ... and commercialization activities," said Jamey Skillings , M.D., ...
(Date:8/26/2014)... , Aug. 26, 2014  Zimmer Holdings, Inc. (NYSE ... announced that its Board of Directors has approved the payment ... quarter of 2014. The cash dividend of ... 31, 2014, to stockholders of record as of the close ... are subject to approval of the Board of Directors and ...
Breaking Medicine Technology:FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 2FDNA Partners with London Medical Databases (LMD) to Provide Long-Awaited Online Access to Leading Dysmorphology Database 3Tocagen Expands Clinical Development Team; 2Tocagen Expands Clinical Development Team; 3
... N.J., July 26, 2011 Watson Pharmaceuticals, Inc. ... definitive agreement to acquire a portfolio of generic ... result of the merger between Perrigo Company and ... including four FDA-approved products and two undisclosed development-stage ...
... N.J., July 26, 2011 The Board of Directors of ... a leading global medical technology company, today announced that, in ... A. Forlenza as Chief Executive Officer and President, effective October ... the Board at that time. Also effective October 1, current ...
Cached Medicine Technology:Watson Enters into Agreement to Acquire Products Related to Perrigo's Acquisition of Paddock Laboratories 2BD Board of Directors Elects Vincent A. Forlenza as Next Chief Executive Officer, Effective October 1, 2011 2BD Board of Directors Elects Vincent A. Forlenza as Next Chief Executive Officer, Effective October 1, 2011 3
(Date:8/27/2014)... Crossing, PA (PRWEB) August 27, 2014 Time ... successfully launched its first-ever golf event! , With 80-degree ... for the Time To Play Golf (TTPGolf) Inaugural Outing. Around ... August 4th event, staged at the beautiful Heron Glen Golf ... with a bang and everyone seemed to be having a ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 PCOS (Polycystic ... and puts them at risk for a number of ... widely known or well understood even within the medical ... excess body hair (hirsutism) and excess body fat around ... aware that their problems are caused by PCOS. , ...
(Date:8/27/2014)... The Connecticut Community for Addiction Recovery (CCAR) ... 2014, from 10:00 AM – 2:00 PM in Bushnell Park ... participants across the state to show their support for recovery ... state capitol. , Recovery Walks! is a celebration for the ... and other drugs as well as their families, friends, and ...
(Date:8/26/2014)... 2014 Recently, BambooIndustry.com, the popular online ... of bamboo floorings for the online market. ... flooring promotion. All the new items are offered at ... The special offer will end on September 10, 2014. ... floorings are provided with low shipping costs. The company ...
(Date:8/26/2014)... (PRWEB) August 27, 2014 In its ... offers treatment programs and believes that having family close ... big difference in whether or not the process is ... without medication. , “While many people need medication to ... withdrawal symptoms and fighting relapse triggers like anxiety and ...
Breaking Medicine News(10 mins):Health News:Recap: Time To Play Golf Inaugural Golf Outing 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:The CT Community for Addiction Recovery to Proudly Host 15th Annual Recovery Walks! 2Health News:Discounted, High Quality Bamboo Floorings Provided Online By BambooIndustry.com 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 2Health News:Latest Best Drug Rehabilitation Blog Post Looks at 6 Ways to Beat Addiction with Medication 3
... the AIDS drug Retrovir (AZT). This generic drug// is manufactured ... be able to market this anti-retroviral drug in US, but ... it will be made available for purchase and use abroad ... emergency plan for AIDS relief was announced in 2003, by ...
... sectional study across Europe, researchers have reported// that there ... the parents and their socio-economic status with the condition ... carried across the countries of Denmark, Estonia, and Portugal, ... Journal (BMJ). ,Across Europe, children from poor families ...
... Gengraine Technologies (Avesthagen) of India is collaborating// with ... Developing Countries (IFU) of Germany for Osteoporosis research. ... euro. Avesthagen said “"The alliance will cover diagnosis, ... disorders.” The research studies related to menopause linked ...
... Technologists annual meeting in US// have warned the general people ... these are illnesses that can threaten the health of the ... ,The studies presented at the meeting said that often people ... illnesses. A healthy adult is less likely to contract a ...
... the research carried out so far into the effects// of ... a new phase III trial is scheduled to commence this ... escalated, causing soaring prices and reports of fake products entering ... been triggered by the publication of Shults’ earlier phase II ...
... (albumin is major part// the protein spectrum in the body) ... study. A simple, inexpensive test for urinary albumin may help ... deliver early. ,A study was released in the American ... Kidney Foundation) this month that suggests this test. "Research ...
Cached Medicine News:Health News:Education And Income Level May Not Guarantee Health 2Health News:Scientists Warn Against Food Borne Illnesses 2Health News:New Study to look at the Beneficial Effects of Coenzyme Q10 on Parkinson’s disease 2Health News:Premature Babies More Likely If Women Have Higher Protein Albumin In Urine 2
Provides reliable information on the most commonly prescribed drugs, their side effects, interactions and cost of therapy....
Ident-A-Drug gives you quick accurate identification of oral tablets and capsules used in North America....
... latest in scientific clinical trial activity and ... resources from CenterWatch. This highly valuable resource ... and stay abreast of medical breakthroughs on ... Trials, Clinical Trial Results, Newly Approved Drugs, ...
Providing patients and their advocates with a variety of information services and educational materials on clinical research....
Medicine Products: